Mobile App for HIV Prevention
(CombineApp Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a mobile app can increase HIV and STI testing and the use of PrEP (a preventive HIV medication) among gay, bisexual, and other men who have sex with men (GBMSM) in rural Southern U.S. Participants will use the Combine mobile app and may receive self-test kits and motivational interviews to enhance their engagement in HIV prevention. The study will compare different combinations of these features to identify the most effective approach. Ideal participants are HIV-negative or unsure of their status, have not used PrEP, and have had anal sex with a man in the past year. As an unphased trial, this study offers participants the chance to contribute to innovative HIV prevention strategies in their community.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that participants should not be currently using PrEP (a medication to prevent HIV).
What prior data suggests that this mobile app is safe for HIV prevention?
Research has shown that the Combine mobile app increases HIV and STI testing. Users of similar apps have experienced positive outcomes without major safety issues. Motivational interviews have helped users plan more effectively for app usage, without causing significant negative effects.
For those using the app with the option to order self-test kits, studies found that this feature led to more frequent testing. These self-test kits are generally safe and easy to use, providing quick results and simple sample collection.
Overall, previous studies have shown that the components of this trial—the Combine app, motivational interviews, and self-test kits—are safe. There have been no major reports of negative effects, suggesting these methods are well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to prevent HIV using a mobile app. Unlike traditional prevention methods, which often rely on regular clinic visits for testing and counseling, this app offers several features that enhance accessibility and convenience. Participants can access an HIV/STI testing locator, receive motivational interviews, and even order free self-test kits directly through the app. This approach aims to make preventive care more engaging and accessible, potentially reaching wider audiences and encouraging proactive health management.
What evidence suggests that this trial's treatments could be effective for increasing HIV and STI testing and PrEP uptake?
Research has shown that mobile apps like Combine can increase HIV and STI testing and encourage the use of pre-exposure prophylaxis (PrEP) among rural men who have sex with men. This trial will evaluate different versions of the Combine app. One arm will offer the app with all features except the ability to order self-test kits. Another arm will include a motivational interview to encourage testing and prevention. A third arm will allow participants to order up to two free HIV/STI self-test kits each year. The final arm combines both the motivational interview and the ability to order test kits via the app. Studies have found that mobile health technology is a promising way to improve HIV prevention. Together, these tools have shown potential to enhance health habits and prevent the spread of HIV.13467
Who Is on the Research Team?
Jeb Jones, PhD
Principal Investigator
Rollins School of Public Health
Are You a Good Fit for This Trial?
This trial is for men aged 18-34 who have had anal sex with another man in the past year, live in rural areas of the U.S. South or Missouri, and are not currently on PrEP. They must be HIV-negative or unsure of their status, own a smartphone with service, speak English, and be willing to use a study app.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the Combine app with various features to increase HIV and STI testing and PrEP initiation
Follow-up
Participants are monitored for the uptake of HIV and STI testing and PrEP initiation
What Are the Treatments Tested in This Trial?
Interventions
- Combine mobile app
- HIV/STI testing
- Motivational interview
Trial Overview
The trial tests if a mobile app called Combine can boost HIV/STI testing and start using PrEP among rural men who have sex with men over two years. Participants will download the app and randomly join one of four groups: control (app only), self-testing (app + test kits), motivational interview (app + planning support), or both self-testing and interview.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Participants will receive a modified standard of care which consists of the Combine app with all features except the ability to order self-test kits. The HIV/STI testing locator in the app will be available.
In addition to the other Combine app features, participants in this arm will receive both the motivational interview and the ability to order HIV/STI test kits via the app.
In addition to the other Combine app features, participants will receive a motivational interview within 4 weeks of downloading the app.
In addition to the other Combine app features, participants in this arm will be able to order up to two HIV/STI self-test kits at no charge during each year of follow-up.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Published Research Related to This Trial
Citations
Evaluating the Effectiveness of a Mobile HIV Prevention App ...
Objective: This study aims to determine the effectiveness of the Combine app to increase HIV testing, STI testing, and PrEP initiation among ...
Evaluating the Effectiveness of a Mobile HIV Prevention ...
This study aims to determine the effectiveness of the Combine app to increase HIV testing, STI testing, and PrEP initiation among rural ...
A Pragmatic Trial to Expand Youth-friendly HIV Self-testing
The primary outcome will be ascertained using a photographic verification approach via a mobile application or a USSD (Unstructured Supplementary Service Data) ...
HIV self-testing and STI self-collection via mobile apps
Both HIV self-testing and STI self-collection kits were highly acceptable, and 87% reported that it was extremely/very helpful to be able to order these kits ...
Evaluating the Effectiveness of a Mobile HIV Prevention ...
The goal of this clinical trial is to test the efficacy of a mobile app, Combine, to increase the uptake of HIV and STI testing and ...
Development and Evaluation of a Mobile App Designed to ...
The aim of this study is to describe the development and evaluate the feasibility and acceptability of the MyChoices app, a mobile app designed to increase HIV ...
Effects of HIV Self-Testing on Testing Promotion and Risk ...
This study aims to evaluate the effects of HIVST on changes in HIV testing behavior, frequency of condomless sex, and partner numbers among transgender women ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.